Inconsistently, NRAS and BRAF in the context of oncogenic, which gain new and tumour-related cellular functions because of nucleotide mutations, MITF turn into oncogenic by deregulating, impacting survival systems that are also described in the general melanocyte lineage. Here, NRAS is linked to neoplasm.